Dexcom (DXCM) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.79% |
| Dec 31, 2025 | -13.64% |
| Sep 30, 2025 | 15.31% |
| Jun 30, 2025 | 2.85% |
| Mar 31, 2025 | 9.13% |
| Dec 31, 2024 | -21.36% |
| Sep 30, 2024 | 9.44% |
| Jun 30, 2024 | 5.78% |
| Mar 31, 2024 | -7.91% |
| Dec 31, 2023 | -13.01% |
| Sep 30, 2023 | 11.87% |
| Jun 30, 2023 | 31.82% |
| Mar 31, 2023 | 8.19% |
| Dec 31, 2022 | 7.79% |
| Sep 30, 2022 | 16.38% |
| Jun 30, 2022 | 13.18% |
| Mar 31, 2022 | 36.07% |
| Dec 31, 2021 | 61.94% |
| Sep 30, 2021 | 71.38% |
| Jun 30, 2021 | 67.65% |
| Mar 31, 2021 | 56.61% |
| Dec 31, 2020 | 56.86% |
| Sep 30, 2020 | 51.17% |
| Jun 30, 2020 | 50.92% |
| Mar 31, 2020 | 60.91% |
| Dec 31, 2019 | 44.11% |
| Sep 30, 2019 | 44.31% |
| Jun 30, 2019 | 70.31% |
| Mar 31, 2019 | 94.90% |
| Dec 31, 2018 | 92.33% |
| Sep 30, 2018 | 61.54% |
| Jun 30, 2018 | 60.48% |
| Mar 31, 2018 | 85.97% |
| Dec 31, 2017 | 122.48% |
| Sep 30, 2017 | 133.61% |
| Jun 30, 2017 | 131.15% |
| Mar 31, 2017 | 97.56% |
| Dec 31, 2016 | 105.16% |
| Sep 30, 2016 | 41.01% |
| Jun 30, 2016 | 20.89% |
| Mar 31, 2016 | 82.91% |
| Dec 31, 2015 | 77.40% |
| Sep 30, 2015 | 72.85% |
| Jun 30, 2015 | 61.88% |